English

NANOBAC PHARMACEUTICALS INC

EDGAR

Filing (10KSB) · filed 2008-04-15

48 filing records in this dataset, filed from 1996-06-24 to 2008-04-15. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

4.37 thousand USD

2007-12-31 · USD

Exact inputs and evidence

Revenue: 17621 USD Source
Revenue: 13253 USD Source

Operating margin

-26,154.01%

2007-12-31 · %

Exact inputs and evidence

Operating Income: -4914811 USD Source
Operating Income: -3772404 USD Source
Revenue: 17621 USD Source
Revenue: 13253 USD Source

Cash and cash equivalents: 0 USD 2000-06-30 Source
Exact value

0 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

17.6 thousand USD

2007-01-01 – 2007-12-31

Exact inputs and evidence

Revenue: 5012 USD · 2007-01-01 – 2007-03-31 Source
Revenue: 2432 USD · 2007-04-01 – 2007-06-30 Source
Revenue: 5809 USD · 2007-07-01 – 2007-09-30 Source
Revenue: 17621 USD · 2007-01-01 – 2007-12-31 Source
Revenue: 13253 USD · 2007-01-01 – 2007-09-30 Source

Net income

-6.58 million USD

2007-01-01 – 2007-12-31

Exact inputs and evidence

Net income: -3856718 USD · 2007-01-01 – 2007-03-31 Source
Net income: -716562 USD · 2007-04-01 – 2007-06-30 Source
Net income: -835763 USD · 2007-07-01 – 2007-09-30 Source
Net income: -6576111 USD · 2007-01-01 – 2007-12-31 Source
Net income: -5409043 USD · 2007-01-01 – 2007-09-30 Source

Operating cash flow

-2.37 million USD

2005-01-01 – 2005-12-31

Exact inputs and evidence

Operating cash flow: -619490 USD · 2005-01-01 – 2005-03-31 Source
Operating cash flow: -1400490 USD · 2005-01-01 – 2005-06-30 Source
Operating cash flow: -619490 USD · 2005-01-01 – 2005-03-31 Source
Operating cash flow: -1761989 USD · 2005-01-01 – 2005-09-30 Source
Operating cash flow: -1400490 USD · 2005-01-01 – 2005-06-30 Source
Operating cash flow: -2365310 USD · 2005-01-01 – 2005-12-31 Source
Operating cash flow: -1761989 USD · 2005-01-01 – 2005-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-04-15.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2007-12-31
Operating income: 8 of 11 periods available· newest 2007-12-31
Net income: 8 of 11 periods available· newest 2007-12-31
Operating cash flow: 6 of 11 periods available· newest 2005-12-31
Capital expenditure: 3 of 11 periods available· newest 1999-12-31
Total assets: 8 of 11 periods available· newest 2007-12-31
Total liabilities: 8 of 11 periods available· newest 2007-12-31
Current assets: 8 of 11 periods available· newest 2007-12-31
Current liabilities: 8 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 1999-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-92.2%

Prior period

USD 225,086

2006-01-01 – 2006-12-31
Current period

USD 17,621

2007-01-01 – 2007-12-31

Exact inputs and evidence

17621 − 225086 = -207465 USD

225086 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
17621 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NANOBAC PHARMACEUTICALS INC · 2007-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Year-over-year change in Revenue: -207465 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 17621 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0001144204-08-022608.txt#8944 Input fundies:Revenue: 225086 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0001144204-08-022608.txt#8944
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 1.6 million

Prior period

−USD 4.97 million

2006-01-01 – 2006-12-31
Current period

−USD 6.58 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-6576111 − -4973353 = -1602758 USD

-4973353 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-6576111 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NANOBAC PHARMACEUTICALS INC · 2007-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Year-over-year change in Net income: -1602758 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -6576111 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0001144204-08-022608.txt#9365 Input fundies:NetIncome: -4973353 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0001144204-08-022608.txt#9365
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 17,621 100% of revenue
Cost of revenue USD 14,519 82% of revenue
Operating expenses USD 4.92 million 27,909% of revenue
Operating income −USD 4.91 million −27,892% of revenue
Tax, interest and other Derived USD 1.66 million 9,428% of revenue
Net income −USD 6.58 million −37,320% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1997 Operating loss: operating costs were 112% of revenue.
1998 Operating loss: operating costs were 123% of revenue.
1999 Operating loss: operating costs were 135% of revenue.
2003 Operating loss: operating costs were 659% of revenue.
2004 Operating loss: operating costs were 2,221% of revenue.
2005 Operating loss: operating costs were 532% of revenue.
2006 Operating loss: operating costs were 2,239% of revenue.
2007 Operating loss: operating costs were 27,992% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1997 1997-01-01 – 1997-12-31	9942050	11182829 Derived	-1240779	669352 Derived	-1910131	218410 Derived	Source 1997-01-01 – 1997-12-31: 9942050 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -1240779 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -1910131 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: 426142 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 207732 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	8774419	10824527 Derived	-2050108	629285 Derived	-2679393	479812 Derived	Source 1998-01-01 – 1998-12-31: 8774419 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -2050108 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -2679393 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: 528004 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 48192 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	6844361	9212441 Derived	-2368080	370992 Derived	-2739072	-213771 Derived	Source 1999-01-01 – 1999-12-31: 6844361 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -2368080 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -2739072 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -72688 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 141083 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	482815	3183026 Derived	-2700211	999280 Derived	-3699491	Unavailable	Source 2003-01-01 – 2003-12-31: 482815 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -2700211 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -3699491 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -2155322 USD Inspect Operating Cash Flow Open source
2004 2004-01-01 – 2004-12-31	358361	7958744 Derived	-7600383	918025 Derived	-8518408	Unavailable	Source 2004-01-01 – 2004-12-31: 358361 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -7600383 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -8518408 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -3395744 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	656802	3494493 Derived	-2837691	849646 Derived	-3687337	Unavailable	Source 2005-01-01 – 2005-12-31: 656802 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -2837691 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -3687337 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -2365310 USD Inspect Operating Cash Flow Open source
2006 2006-01-01 – 2006-12-31	225086	5039620 Derived	-4814534	158819 Derived	-4973353	Unavailable	Source 2006-01-01 – 2006-12-31: 225086 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -4814534 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -4973353 USD Inspect Net Income Open source
2007 2007-01-01 – 2007-12-31	17621	4932432 Derived	-4914811	1661300 Derived	-6576111	Unavailable	Source 2007-01-01 – 2007-12-31: 17621 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -4914811 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -6576111 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 17.6K 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Revenue	9942050	Revenue: 9942050 Open source
19981998-12-31	Revenue	8774419	Revenue: 8774419 Open source
19991999-12-31	Revenue	6844361	Revenue: 6844361 Open source
20032003-12-31	Revenue	482815	Revenue: 482815 Open source
20042004-12-31	Revenue	358361	Revenue: 358361 Open source
20052005-12-31	Revenue	656802	Revenue: 656802 Open source
20062006-12-31	Revenue	225086	Revenue: 225086 Open source
20072007-12-31	Revenue	17621	Revenue: 17621 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-92.2% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Year over year	No prior comparable period	Revenue: 9942050 Open source
19981998-12-31	Year over year	-11.7%	Revenue: 8774419 Open source Revenue: 9942050 Open source
19991999-12-31	Year over year	-22%	Revenue: 6844361 Open source Revenue: 8774419 Open source
20032003-12-31	Year over year	No prior comparable period	Revenue: 482815 Open source
20042004-12-31	Year over year	-25.8%	Revenue: 358361 Open source Revenue: 482815 Open source
20052005-12-31	Year over year	83.3%	Revenue: 656802 Open source Revenue: 358361 Open source
20062006-12-31	Year over year	-65.7%	Revenue: 225086 Open source Revenue: 656802 Open source
20072007-12-31	Year over year	-92.2%	Revenue: 17621 Open source Revenue: 225086 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -27,891.8% 2007

Net margin -37,319.7% 2007

Free cash flow margin -3.1% 1999

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Operating margin	-12.5%	Operating Income: -1240779 Open source Revenue: 9942050 Open source
19981998-12-31	Operating margin	-23.4%	Operating Income: -2050108 Open source Revenue: 8774419 Open source
19991999-12-31	Operating margin	-34.6%	Operating Income: -2368080 Open source Revenue: 6844361 Open source
20032003-12-31	Operating margin	-559.3%	Operating Income: -2700211 Open source Revenue: 482815 Open source
20042004-12-31	Operating margin	-2,120.9%	Operating Income: -7600383 Open source Revenue: 358361 Open source
20052005-12-31	Operating margin	-432%	Operating Income: -2837691 Open source Revenue: 656802 Open source
20062006-12-31	Operating margin	-2,139%	Operating Income: -4814534 Open source Revenue: 225086 Open source
20072007-12-31	Operating margin	-27,891.8%	Operating Income: -4914811 Open source Revenue: 17621 Open source
19971997-12-31	Net margin	-19.2%	Net Income: -1910131 Open source Revenue: 9942050 Open source
19981998-12-31	Net margin	-30.5%	Net Income: -2679393 Open source Revenue: 8774419 Open source
19991999-12-31	Net margin	-40%	Net Income: -2739072 Open source Revenue: 6844361 Open source
20032003-12-31	Net margin	-766.2%	Net Income: -3699491 Open source Revenue: 482815 Open source
20042004-12-31	Net margin	-2,377%	Net Income: -8518408 Open source Revenue: 358361 Open source
20052005-12-31	Net margin	-561.4%	Net Income: -3687337 Open source Revenue: 656802 Open source
20062006-12-31	Net margin	-2,209.5%	Net Income: -4973353 Open source Revenue: 225086 Open source
20072007-12-31	Net margin	-37,319.7%	Net Income: -6576111 Open source Revenue: 17621 Open source
19971997-12-31	Free cash flow margin	2.2%	Revenue: 9942050 Open source Operating Cash Flow: 426142 Open source Capital Expenditure: 207732 Open source
19981998-12-31	Free cash flow margin	5.5%	Revenue: 8774419 Open source Operating Cash Flow: 528004 Open source Capital Expenditure: 48192 Open source
19991999-12-31	Free cash flow margin	-3.1%	Revenue: 6844361 Open source Operating Cash Flow: -72688 Open source Capital Expenditure: 141083 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 482815 Open source Operating Cash Flow: -2155322 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 358361 Open source Operating Cash Flow: -3395744 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 656802 Open source Operating Cash Flow: -2365310 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 225086 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 17621 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -2.4M 2005

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Operating cash flow	426142	Operating Cash Flow: 426142 Open source
19981998-12-31	Operating cash flow	528004	Operating Cash Flow: 528004 Open source
19991999-12-31	Operating cash flow	-72688	Operating Cash Flow: -72688 Open source
20032003-12-31	Operating cash flow	-2155322	Operating Cash Flow: -2155322 Open source
20042004-12-31	Operating cash flow	-3395744	Operating Cash Flow: -3395744 Open source
20052005-12-31	Operating cash flow	-2365310	Operating Cash Flow: -2365310 Open source
20062006-12-31	Operating cash flow	Not reported	No source recorded
20072007-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -213.8K 1999

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Free cash flow	218410	Operating Cash Flow: 426142 Open source Capital Expenditure: 207732 Open source
19981998-12-31	Free cash flow	479812	Operating Cash Flow: 528004 Open source Capital Expenditure: 48192 Open source
19991999-12-31	Free cash flow	-213771	Operating Cash Flow: -72688 Open source Capital Expenditure: 141083 Open source
20032003-12-31	Free cash flow	Unavailable	Operating Cash Flow: -2155322 Open source
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: -3395744 Open source
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: -2365310 Open source
20062006-12-31	Free cash flow	Unavailable	No source recorded
20072007-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

132.7% 2007

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Liabilities / assets	113.1%	Total Liabilities: 9167226 Open source Total Assets: 8108847 Open source
19981998-12-31	Liabilities / assets	146%	Total Liabilities: 9717765 Open source Total Assets: 6653993 Open source
19991999-12-31	Liabilities / assets	194.1%	Total Liabilities: 10695774 Open source Total Assets: 5509662 Open source
20032003-12-31	Liabilities / assets	149.7%	Total Liabilities: 9050246 Open source Total Assets: 6044090 Open source
20042004-12-31	Liabilities / assets	36.9%	Total Liabilities: 3573463 Open source Total Assets: 9684307 Open source
20052005-12-31	Liabilities / assets	72.5%	Total Liabilities: 6505003 Open source Total Assets: 8969724 Open source
20062006-12-31	Liabilities / assets	116.8%	Total Liabilities: 9136383 Open source Total Assets: 7824721 Open source
20072007-12-31	Liabilities / assets	132.7%	Total Liabilities: 9582022 Open source Total Assets: 7219762 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Current assets / current liabilities	0.26×	Current Assets: 2207550 Open source Current Liabilities: 8398026 Open source
19981998-12-31	Current assets / current liabilities	0.27×	Current Assets: 2021846 Open source Current Liabilities: 7466919 Open source
19991999-12-31	Current assets / current liabilities	0.2×	Current Assets: 2085731 Open source Current Liabilities: 10695774 Open source
20032003-12-31	Current assets / current liabilities	0.01×	Current Assets: 86611 Open source Current Liabilities: 6850246 Open source
20042004-12-31	Current assets / current liabilities	0.09×	Current Assets: 115523 Open source Current Liabilities: 1304833 Open source
20052005-12-31	Current assets / current liabilities	0.05×	Current Assets: 173263 Open source Current Liabilities: 3668465 Open source
20062006-12-31	Current assets / current liabilities	0.02×	Current Assets: 126503 Open source Current Liabilities: 6299845 Open source
20072007-12-31	Current assets / current liabilities	0×	Current Assets: 30761 Open source Current Liabilities: 6745484 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1997 1997-01-01 – 1997-12-31	−USD 1.91 million Exact value Exact value: -1910131 USD 1997-01-01 – 1997-12-31: -1910131 USD Inspect Net Income Open source Share or cite Citation for Net Income · NANOBAC PHARMACEUTICALS INC · 1997-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Net Income: -1910131 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1910131 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950144-99-006868.txt#2130 The citation records this snapshot. The page link may show a newer release later.	USD 426,142 Exact value Exact value: 426142 USD 1997-01-01 – 1997-12-31: 426142 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBAC PHARMACEUTICALS INC · 1997-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Operating Cash Flow: 426142 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 426142 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950144-99-006868.txt#2146 The citation records this snapshot. The page link may show a newer release later.	USD 207,732 Exact value Exact value: 207732 USD 1997-01-01 – 1997-12-31: 207732 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NANOBAC PHARMACEUTICALS INC · 1997-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Capital Expenditure: 207732 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 207732 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950144-99-006868.txt#2151 The citation records this snapshot. The page link may show a newer release later.	USD 218,410 Calculation and evidence 426142 − 207732 USD Exact free cash flow: 218410 USD 1997-01-01 – 1997-12-31: 426142 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 207732 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NANOBAC PHARMACEUTICALS INC · 1997-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Free cash flow: 218410 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 426142 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950144-99-006868.txt#2146 Input fundies:CapitalExpenditure: 207732 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950144-99-006868.txt#2151 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 2.68 million Exact value Exact value: -2679393 USD 1998-01-01 – 1998-12-31: -2679393 USD Inspect Net Income Open source Share or cite Citation for Net Income · NANOBAC PHARMACEUTICALS INC · 1998-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Net Income: -2679393 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2679393 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950168-00-001015.txt#2024 The citation records this snapshot. The page link may show a newer release later.	USD 528,004 Exact value Exact value: 528004 USD 1998-01-01 – 1998-12-31: 528004 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBAC PHARMACEUTICALS INC · 1998-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Operating Cash Flow: 528004 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 528004 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950168-00-001015.txt#2041 The citation records this snapshot. The page link may show a newer release later.	USD 48,192 Exact value Exact value: 48192 USD 1998-01-01 – 1998-12-31: 48192 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NANOBAC PHARMACEUTICALS INC · 1998-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Capital Expenditure: 48192 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 48192 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950168-00-001015.txt#2045 The citation records this snapshot. The page link may show a newer release later.	USD 479,812 Calculation and evidence 528004 − 48192 USD Exact free cash flow: 479812 USD 1998-01-01 – 1998-12-31: 528004 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 48192 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NANOBAC PHARMACEUTICALS INC · 1998-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Free cash flow: 479812 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 528004 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950168-00-001015.txt#2041 Input fundies:CapitalExpenditure: 48192 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950168-00-001015.txt#2045 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 2.74 million Exact value Exact value: -2739072 USD 1999-01-01 – 1999-12-31: -2739072 USD Inspect Net Income Open source Share or cite Citation for Net Income · NANOBAC PHARMACEUTICALS INC · 1999-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Net Income: -2739072 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2739072 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950168-00-001015.txt#2024 The citation records this snapshot. The page link may show a newer release later.	−USD 72,688 Exact value Exact value: -72688 USD 1999-01-01 – 1999-12-31: -72688 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBAC PHARMACEUTICALS INC · 1999-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Operating Cash Flow: -72688 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -72688 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950168-00-001015.txt#2041 The citation records this snapshot. The page link may show a newer release later.	USD 141,083 Exact value Exact value: 141083 USD 1999-01-01 – 1999-12-31: 141083 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NANOBAC PHARMACEUTICALS INC · 1999-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Capital Expenditure: 141083 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 141083 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950168-00-001015.txt#2045 The citation records this snapshot. The page link may show a newer release later.	−USD 213,771 Calculation and evidence -72688 − 141083 USD Exact free cash flow: -213771 USD 1999-01-01 – 1999-12-31: -72688 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 141083 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NANOBAC PHARMACEUTICALS INC · 1999-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Free cash flow: -213771 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -72688 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950168-00-001015.txt#2041 Input fundies:CapitalExpenditure: 141083 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0000950168-00-001015.txt#2045 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 3.7 million Exact value Exact value: -3699491 USD 2003-01-01 – 2003-12-31: -3699491 USD Inspect Net Income Open source Share or cite Citation for Net Income · NANOBAC PHARMACEUTICALS INC · 2003-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Net Income: -3699491 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3699491 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0001144204-05-025839.txt#8709 The citation records this snapshot. The page link may show a newer release later.	−USD 2.16 million Exact value Exact value: -2155322 USD 2003-01-01 – 2003-12-31: -2155322 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBAC PHARMACEUTICALS INC · 2003-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Operating Cash Flow: -2155322 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2155322 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0001144204-05-025839.txt#9054 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 8.52 million Exact value Exact value: -8518408 USD 2004-01-01 – 2004-12-31: -8518408 USD Inspect Net Income Open source Share or cite Citation for Net Income · NANOBAC PHARMACEUTICALS INC · 2004-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Net Income: -8518408 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8518408 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0001144204-06-013205.txt#11948 The citation records this snapshot. The page link may show a newer release later.	−USD 3.4 million Exact value Exact value: -3395744 USD 2004-01-01 – 2004-12-31: -3395744 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBAC PHARMACEUTICALS INC · 2004-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Operating Cash Flow: -3395744 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3395744 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0001144204-06-013205.txt#12276 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 3.69 million Exact value Exact value: -3687337 USD 2005-01-01 – 2005-12-31: -3687337 USD Inspect Net Income Open source Share or cite Citation for Net Income · NANOBAC PHARMACEUTICALS INC · 2005-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Net Income: -3687337 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3687337 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0001144204-07-022902.txt#8965 The citation records this snapshot. The page link may show a newer release later.	−USD 2.37 million Exact value Exact value: -2365310 USD 2005-01-01 – 2005-12-31: -2365310 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBAC PHARMACEUTICALS INC · 2005-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Operating Cash Flow: -2365310 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2365310 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0001144204-06-013205.txt#12276 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 4.97 million Exact value Exact value: -4973353 USD 2006-01-01 – 2006-12-31: -4973353 USD Inspect Net Income Open source Share or cite Citation for Net Income · NANOBAC PHARMACEUTICALS INC · 2006-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Net Income: -4973353 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4973353 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0001144204-08-022608.txt#9365 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 6.58 million Exact value Exact value: -6576111 USD 2007-01-01 – 2007-12-31: -6576111 USD Inspect Net Income Open source Share or cite Citation for Net Income · NANOBAC PHARMACEUTICALS INC · 2007-12-31 NANOBAC PHARMACEUTICALS INC (edgar:925894) Net Income: -6576111 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/925894/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6576111 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/925894/0001144204-08-022608.txt#9365 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

48 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000925894, 925894, edgar:925894

Also known as AMERICAN ENTERPRISE COM CORP, AMERICAN ENTERPRISE CORP, NATIONAL DIAGNOSTICS INC

NANOBAC PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation